Skip to main content

Advertisement

Fig. 1 | Cell & Bioscience

Fig. 1

From: Label-free quantitative proteomics identifies transforming growth factor β1 (TGF-β1) as an inhibitor of adipogenic transformation in OP9-DL1 cells and primary thymic stromal cells

Fig. 1

Proteomic analysis of proteins differed significantly in rosiglitazone-treated cells compared with dimethyl sulphoxide (DMSO)-treated cells. a Heatmap of significantly altered proteins between rosiglitazone- and DMSO-treated OP9-DL1 cells (n = 3). GO enrichment analysis (b) and KEGG pathway analysis (c) of all differentially expressed proteins due to rosiglitazone treatment. Rosi rosiglitazone

Back to article page